Morrisville, North Carolina
United States
25
2025-01-09
18
2024-05-21
These are the the leading inventors for applications assigned to LipoScience, Inc.:
LipoScience, Inc. based in Morrisville, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
MULTI-PARAMETER METABOLIC VULNERABILITY INDEX EVALUATIONS
#2 | 2024-09-12Multiple-Marker Risk Parameters Predictive of Conversion to Diabetes
#3 | 2024-09-12Cardiovascular Risk Evaluations Using a Risk Parameter That Includes an HDL and Inflammatory Biomarker Interaction Parameter
#4 | 2024-09-05Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements
#5 | 2024-04-18NMR Quantification of TMAO
#6 | 2024-03-21Multi-Parameter Diabetes Risk Evaluations
#7 | 2022-05-05 ✅ Patent 11,988,679 granted on 2024-05-21Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
#8 | 2022-02-10NMR Analyzers for Clinical Evaluation of Biosamples
#9 | 2022-02-10 ✅ Patent 12,130,295 granted on 2024-10-29NMR system and methods for multi-parameter metabolic vulnerability index evaluations
#10 | 2021-09-30 ✅ Patent 11,990,243 granted on 2024-05-21Multiple-marker risk parameters predictive of conversion to diabetes
#11 | 2021-03-18 ✅ Patent 11,692,995 granted on 2023-07-04NMR measurements of NMR biomarker GlycA
#12 | 2020-11-12 ✅ Patent 11,782,002 granted on 2023-10-10NMR quantification of TMAO
#13 | 2020-02-27 ✅ Patent 11,942,187 granted on 2024-03-26Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements
#14 | 2020-01-02 ✅ Patent 11,710,568 granted on 2023-07-25Multi-parameter diabetes risk evaluations
#15 | 2020-01-02 ✅ Patent 11,703,501 granted on 2023-07-18CHD risk stratification evaluations for subjects with high levels of large HDL-P
#16 | 2019-10-17 ✅ Patent 11,156,685 granted on 2021-10-26NMR analyzers for clinical evaluation of biosamples
#17 | 2019-03-07 ✅ Patent 11,156,621 granted on 2021-10-26Multi-parameter metabolic vulnerability index evaluations
#18 | 2018-07-12 ✅ Patent 11,231,429 granted on 2022-01-25Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
#19 | 2018-06-07 ✅ Patent 11,037,683 granted on 2021-06-15Multiple-marker risk parameters predictive of conversion to diabetes
#20 | 2017-06-29 ✅ Patent 10,613,044 granted on 2020-04-07NMR quantification of TMAO
#21 | 2017-03-23 ✅ Patent 10,504,610 granted on 2019-12-10Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements
#22 | 2017-01-19 ✅ Patent 10,386,355 granted on 2019-08-20CHD risk stratification evaluations for subjects with high levels of large HDL-P
#23 | 2017-01-05 ✅ Patent 10,852,293 granted on 2020-12-01NMR measurements of NMR biomarker GlycA
#24 | 2016-11-03 ✅ Patent 10,388,414 granted on 2019-08-20Multi-parameter diabetes risk evaluations
#25 | 2016-03-17 ✅ Patent 9,952,232 granted on 2018-04-24Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter
Also check out LipoScience, Inc.'s (Morrisville, United States) applicant profile with 18 patent applications submitted.
135921 ⎘